Logo

Vox Markets

Q&A with Oncimmune CEO, Dr Adam M Hill

Q&A with Oncimmune CEO, Dr Adam M Hill

74 views
2 years ago
Author: Vox Markets

In this interview, CEO Adam Hill takes me through Oncimune's in line FY’22 results, exciting growth trajectory & positive outlook. Alongside detailing its path to profitability and near-term funding options.

Vox Markets
Company News
trading
investing
stocks
shares
Small caps
mid caps
Stocks to Follow
Hot Stocks
Stock Market
Money
AIM
London Stock Exchange
ONC
Powered bySeeen logo